OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 21 - 30 of 773 studies

Cancer and neoplasms

PLANET study: Planning for End of Treatment – sharing information to prepare children, young people and families to move into survivorship care when active treatment finishes

Previous research has highlighted that children,young people and families have unmet information needs at the end of treatment. We do not currently know whether children,young people and families in the UK are receiving the information they need at the end of treatment and how far children and young people are included in the conversations. Provision of information at the end of treatment sets the foundations for children and young people being able to successfully engage with future long-term follow up services ...

GO TO STUDY Go

Blood Reproductive health and childbirth

Transfusion with washed versus unwashed red blood cells to reduce morbidity and mortality in infants born less than 28 weeks gestation: a multi-centre, blinded, parallel group, randomised controlled trial. The WashT trial. (WashT)

While blood transfusions save lives in the neonatal critical care setting, there is increasing awareness that transfusion of blood products is an independent predictor of adverse outcome. Infants in a neonatal intensive care unit (NICU) are among the most frequently transfused patients with the incidence and severity of major neonatal morbidities known to correlate with the number and volume of red blood cell (RBC) transfusions they receive. The spectrum of post-transfusion effects on organs and tissues which manifest ...

GO TO STUDY Go

Oral and Gastrointestinal

A phase II, double-blind, randomised, placebo-controlled trial to evaluate the efficacy and tolerability of ZED1227 in celiac disease subjects experiencing symptoms despite gluten-free diet (CEC-013/CEL)

This is a double-blind, randomised, multicentre, placebo-controlled, comparative phase II efficacy trial. The trial will be conducted with two treatment groups in the form of a parallel group comparison and will serve to compare oral treatment with daily doses of 75 mg [25 mg three times a day (TID)] and potentially 30 mg (10 mg TID) of ZED1227 vs placebo for treatment of celiac disease. The screening period will be up to 4 weeks, followed by a 3-week single-blind placebo run-in ...

GO TO STUDY Go

Injuries and accidents

Identifying delays in Diagnosis of Carbon Monoxide in the Emergency Department (EDCO-D)

Study Aim To investigate how often diagnostic delays or errors of carbon monoxide (CO) poisoning happen in Emergency Departments (EDs) in UK. Background Carbon monoxide (CO) poisoning is a common but often overlooked medical emergency. CO poisoning occurs when people are exposed to this odourless and invisible gas, often produced by faulty heaters, car engines, or other fuel-burning appliances. Symptoms like headaches, dizziness, or nausea can be confused with other illnesses, making diagnosis difficult. If not recognised quickly, CO poisoning can ...

GO TO STUDY Go

Neurological

A multicentre, interventional, multi-arm, multi-stage trial including randomisation, double blinding, placebo control evaluation of treatments for slowing the progression of disability in participants with Secondary Progressive Multiple Sclerosis (SPMS) and Primary Progressive Multiple Sclerosis (PPMS), together termed Progressive Multiple Sclerosis (PMS) (OCTOPUS)

Multiple sclerosis (MS) affects more than 130,000 people in the UK and over 2.5 million people worldwide. MS often begins with a relapsing-remitting phase (RRMS). However,over time,many people with RRMS start to find that they no longer recover after a flare-up (also known as a relapse) and get steadily worse,resulting in increased disability. This is known as secondary progressive MS (SPMS). A smaller number of people experience a gradual decline from the beginning,known as primary progressive MS (PPMS). SPMS and ...

GO TO STUDY Go

Cancer and neoplasms

Post-operative radiotherapy in surgically treated bone metastases (PORTRAIT) – a multi-centre, randomised controlled trial

Research question: Does post-operative radiotherapy following surgery for pathological fractures improve pain and quality of life? Background: Approximately 70% of people with advanced breast and prostate cancer develop bone metastases, causing ‘pathological’ fractures requiring surgery to stabilise or replace the affected bone. Following surgery, patients usually receive radiotherapy (RT). Despite widespread use, no high-quality evidence exists that post-operative RT improves pain, quality of life nor reduces the risk of re-operation. RT has side-effects, requires additional hospital visits and scans, can delay other effective ...

GO TO STUDY Go

Eye Reproductive health and childbirth

Assessing Physiological Risk Factors for Retinopathy of Prematurity (ROP) Progression and Effects of Anti-VEGF Therapy on Neurodevelopment: PROGRESS-ROP Study

1 in 3 babies born prematurely before 32 weeks are at risk of developing retinopathy of prematurity (ROP), a condition caused by abnormal growth of blood vessels in the retina. ROP is a leading cause of childhood blindness worldwide and can significantly impact a child’s quality of life. In 2010, a clinical trial showed that a treatment called anti-VEGF, which works by stopping abnormal blood vessel growth, is effective in treating ROP. As a result, it has been widely used ...

GO TO STUDY Go

Neurological

The Cauda Equina Syndrome Early Recognition (CESER) Study: a mixed-methods study to improve diagnosis of cauda equina syndrome in the Emergency Department

Cauda equina syndrome (CES) describes symptoms caused by a disc from the spine pushing on the nerves at the end of the spinal cord. These nerves supply the legs, bladder, anus and sexual organs, and can become damaged if compressed for too long. Most patients with CES require an emergency operation to take pressure off the nerves. First, we will recruit 2000 patients admitted with suspected CES across a number of NHS hospitals. These patients will be examined carefully by ...

GO TO STUDY Go

Generic health relevance

The VIP-3 study: Decision-making in the older ICU patient: How are family meetings implemented across diverse European cultures? (VIP-3)

The demographics of the global population is changing with increasing numbers of elderly and co-morbid patients. As a result, more elderly patients will be admitted to ICU, which will bring a number of ethical challenges. It is for this reason we have chosen to focus on this historically neglected and important patient population. Little is known about how or whether Family meetings (FM) are conducted in European ICUs. The aim of this trial is to determine whether FMs are ...

GO TO STUDY Go

Cancer and neoplasms Respiratory

Standardising Outcomes in Malignant Pleural Effusion Interventional Trials - The STANDOUT MPE study

Doctors and patients need to have evidence from clinical trials so that they can make the right treatment choices together. However, Malignant Pleural Effusion (MPE) trial results cannot be easily compared because they do not all measure the same information or ‘outcomes’ (e.g. pain.) This is because there is no agreement on which outcomes are the most important to patients with MPE, doctors and researchers. My study aims to address this by creating a core outcome set (COS). To ...

GO TO STUDY Go